Morganella morganii early onset sepsis.
Rowen
J L
JL
Department of Pediatrics, University of Texas Medical Branch, Galveston, USA.
Lopez
S M
SM
D000328:Adult; D000668:Ampicillin Resistance; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy; D002439:Cefotaxime / Q000008:administration & dosage; D015377:Cilastatin / Q000008:administration & dosage; D000077728:Cilastatin, Imipenem Drug Combination; D004334:Drug Administration Schedule; D004338:Drug Combinations; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000008:administration & dosage; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011511:Proteus / Q000302:isolation & purification*; D011512:Proteus Infections / Q000175:diagnosis* / Q000188:drug therapy; D011645:Puerperal Infection / Q000188:drug therapy; D016896:Treatment Outcome
D004338:Drug Combinations; D005839:Gentamicins; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination; D002439:Cefotaxime